Process Robustness for Tablet Compression at Commercial Scale


Published on 03/06/2026

Ensuring Process Robustness for Tablet Compression in Commercial Manufacturing

Pharmaceutical manufacturers face numerous challenges when scaling up tablet compression processes to commercial levels. A real-world scenario involved a sudden increase in tablet defects linked to variations in compression parameters. This article guides you through the critical steps of detection, containment, investigation, CAPA (Corrective and Preventive Action), and lessons learned. By the end, you will understand how to enhance your process robustness at scale effectively.

This case study outlines a systematic approach that can be implemented in a GMP-compliant framework. By addressing the specific issues faced during tablet compression, you can optimize your operational efficiency and maintain compliance with regulatory expectations in the US, UK, and EU.

Symptoms/Signals on the Floor or in the Lab

The manufacturing floor became the epicenter of concern when operators started noticing abnormal symptoms in the tablet batches. Symptoms included:

  • Increased tablet weight variability beyond the established control limits.
  • Higher incidences of capping and chipping on tablets, leading to increased quality control rejects.
  • Variability in tablet hardness, with some batches
falling below the specified threshold.
  • Inconsistent tablet disintegration times, which affected dissolution profiles.
  • These signals were documented meticulously through batch records and QC logs, enabling a structured response and review process. RCA (Root Cause Analysis) initiated once the flags were raised, indicating the necessary urgency to assess the situation and mitigate risks.

    Likely Causes (by category: Materials, Method, Machine, Man, Measurement, Environment)

    Upon initial evaluation, various categories were considered regarding the variation in tablet quality:

    Category Potential Causes
    Materials Inconsistent raw material properties (API or excipients), moisture content fluctuations, or supplier quality variations.
    Method Changes in compression technique or inadequate control of parameters leading to inconsistencies.
    Machine Equipment malfunction, inappropriate maintenance schedules, or changes in tooling.
    Man Operator error linked to training deficiencies or lack of procedural adherence.
    Measurement Inaccuracies in measurement tools affecting weight and hardness assessments.
    Environment Variations in temperature and humidity affecting material properties and processing conditions.

    Immediate Containment Actions (first 60 minutes)

    Once the symptoms were identified, immediate containment actions were initiated within the first hour:

    1. Pause the production line to prevent further defectives from being processed.
    2. Isolate affected batches and quarantine materials until the investigation concludes.
    3. Notify quality control and relevant department personnel to initiate a full review of parameters and scale-up processes.
    4. Review the trend data that led to the batch deviations against both validated control parameters and historical performance.

    By executing these containment actions swiftly, the manufacturing team minimized risk and safeguarded product integrity while ensuring alignment with compliance expectations.

    Investigation Workflow (data to collect + how to interpret)

    The investigation workflow was established, focusing on data collection across several domains:

    1. Batch Records & Logs: Comprehensive review of batch records, production and maintenance logs were conducted to identify anomalies.
    2. Trend Analysis: Comparison of current batch data against historical data to find deviations.
    3. Operator Interviews: Engage with operators to capture insights into recent operational changes or challenges encountered during the compression process.
    4. Environmental Conditions: Monitoring logs of temperature and humidity were checked to identify fluctuations that could correlate with the tablet quality issues.

    Interpretation involved correlating this data to pinpoint deficiencies, which guided further analysis and eventual root cause investigations.

    Root Cause Tools (5-Why, Fishbone, Fault Tree) and when to use which

    Several tools were employed to determine the root causes of the identified issues:

    • 5-Why Analysis: This tool was instrumental in drilling down the fundamental issues by repeatedly asking “why” the problem occurred. For instance, why did we experience weight variability? Further probing indicated raw material inconsistencies.
    • Fishbone Diagram: This tool facilitated a visual brainstorming session, classifying potential causes under categories of method, machine, man, and environment. It was a collaborative exercise, engaging cross-functional teams to ensure comprehensive insights.
    • Fault Tree Analysis: For complex issues, this deductive reasoning approach effectively identified possible fault avenues that led to the outcomes, suitable when evaluating equipment failure impact or interactions of multiple failure modes.

    CAPA Strategy (correction, corrective action, preventive action)

    Based on the findings from the investigations, an effective CAPA strategy was formulated:

    Related Reads

    1. Correction: Immediate correction involved recalibrating the compression equipment and adjusting material handling procedures to eliminate immediate variations.
    2. Corrective Action:
      • Implementing stricter quality assessments for raw materials, including tighter supplier management and oversight.
      • Enhancing training programs for operators to include specific scenarios of handling equipment and processing variables.
    3. Preventive Action:
      • Integrating a formalized change control process to assess any deviations from established operating procedures.
      • Deploying continuous process verification practices to monitor key performance metrics closely, enabling early detection of potential issues.

    Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

    To ensure ongoing compliance and process robustness, a comprehensive control strategy was put in place:

    • Statistical Process Control (SPC): Monitoring weight, hardness, and dissolution metrics through real-time data collection.
    • Sampling Plans: Implementing increased sampling frequency during initial runs post-CAPA implementation, gradually reducing frequency based on consistent performance data.
    • Alarms: Setting automated alarms for parameters deviating beyond defined limits to facilitate immediate attention and intervention.
    • Validation of Changes: Each adjustment in the process was subject to validation protocols, ensuring regulatory compliance while safeguarding product integrity.

    Validation / Re-qualification / Change Control impact (when needed)

    Volatility in tablet quality underpinned the need for thorough validation of any changes made during this investigation process. The management employed the following approaches:

    • Validation: All changes made to compression parameters and material specifications needed validation under the ICH guidelines to assure consistent output.
    • Re-qualification: Conducted on the compression machines after adjustments in-line with established qualification protocols to maintain equipment reliability.
    • Change Control: A formal change control process was implemented to encapsulate all deviations, ensuring any future alterations were comprehensively assessed and documented in adherence to regulatory expectations.

    Inspection Readiness: what evidence to show (records, logs, batch docs, deviations)

    For ongoing inspection readiness, the following documentation was prepared and maintained:

    • Batch Production Records: Detailed batch records encompassing all data pertaining to materials, setup parameters, and equipment readings during production.
    • Deviation Reports: Documentation of any deviations from expected practices alongside thorough rationales and actions taken.
    • Training Records: Tracking of employee training and retraining sessions on updated processes to demonstrate compliance with quality management standards.
    • Monitoring Logs: Inclusion of SPC data, sampling results, and equipment maintenance activities to verify ongoing compliance and readiness.

    FAQs

    1. What are the first steps in responding to a tablet manufacturing quality issue?

    Immediate response includes halting production, quarantining affected batches, and reviewing quality control logs.

    2. How do you determine whether to apply CAPA or other strategies?

    Evaluate the severity and prevalence of the quality issue, determining if immediate correction or systemic changes are necessary.

    3. What is the purpose of a Fishbone diagram in quality investigations?

    The Fishbone diagram aids in identifying potential causes in a structured format, ensuring comprehensive issue analysis across various categories.

    4. How can SPC be used effectively in pharmaceutical manufacturing?

    SPC monitors critical parameters in real time, enabling early detection of trends that may lead to quality deviations.

    5. When should change control be initiated?

    Change control should be enacted any time a process, material, or equipment modification occurs that may impact product quality or compliance.

    6. What documents are vital for inspection readiness?

    Key documents include batch records, deviation reports, training records, and monitoring logs, showcasing adherence to established quality systems.

    7. Why is training important for manufacturing personnel?

    Continuous training ensures personnel stay updated with processes and compliance requirements, reducing the risk of human error.

    8. How do we define a quality issue in tablet manufacturing?

    A quality issue is typically any deviation from established specifications that could affect the safety, efficacy, or quality of the product.

    If you find our Articles useful
    Add us as preferred source on Google
    Pharma Tip:  Process Robustness Failures That Appear Only at Commercial Scale
    If you find our Articles useful
    Add us as preferred source on Google